371 related articles for article (PubMed ID: 8943038)
41. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc.
Unniraman S; Zhou S; Schatz DG
Nat Immunol; 2004 Nov; 5(11):1117-23. PubMed ID: 15489857
[TBL] [Abstract][Full Text] [Related]
42. Promiscuity of translocation partners in multiple myeloma.
Martin LD; Belch AR; Pilarski LM
J Cell Biochem; 2010 Apr; 109(6):1085-94. PubMed ID: 20127714
[TBL] [Abstract][Full Text] [Related]
43. IGH switch breakpoints in Burkitt lymphoma: exclusive involvement of noncanonical class switch recombination.
Guikema JE; de Boer C; Haralambieva E; Smit LA; van Noesel CJ; Schuuring E; Kluin PM
Genes Chromosomes Cancer; 2006 Sep; 45(9):808-19. PubMed ID: 16736499
[TBL] [Abstract][Full Text] [Related]
44. Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region.
Shansab M; Eccleston JM; Selsing E
Eur J Immunol; 2011 May; 41(5):1456-64. PubMed ID: 21469111
[TBL] [Abstract][Full Text] [Related]
45. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
46. [The origin and formation of chromosomal translocations in multiple myeloma].
Nemec P; Kuglík P; Hájek R
Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
[TBL] [Abstract][Full Text] [Related]
47. Molecular analysis of 11q13 breakpoints in multiple myeloma.
Ronchetti D; Finelli P; Richelda R; Baldini L; Rocchi M; Viggiano L; Cuneo A; Bogni S; Fabris S; Lombardi L; Maiolo AT; Neri A
Blood; 1999 Feb; 93(4):1330-7. PubMed ID: 9949176
[TBL] [Abstract][Full Text] [Related]
48. Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation.
Stamatopoulos K; Kosmas C; Belessi C; Kyriazopoulos P; Papadaki T; Anagnostou D; Loukopoulos D
Br J Haematol; 1999 Apr; 105(1):190-7. PubMed ID: 10233383
[TBL] [Abstract][Full Text] [Related]
49. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
Tian E; Sawyer JR; Heuck CJ; Zhang Q; van Rhee F; Barlogie B; Epstein J
Genes Chromosomes Cancer; 2014 Jul; 53(7):549-57. PubMed ID: 24638926
[TBL] [Abstract][Full Text] [Related]
50. Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma.
Szczepański T; van 't Veer MB; Wolvers-Tettero IL; Langerak AW; van Dongen JJ
Blood; 2000 Aug; 96(3):1087-93. PubMed ID: 10910926
[TBL] [Abstract][Full Text] [Related]
51. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
[TBL] [Abstract][Full Text] [Related]
52. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
53. Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell lines.
Irsch J; Wolf J; Tesch H; Diehl V; Radbruch A; Staratschek-Jox A
Br J Haematol; 2001 Jun; 113(3):785-93. PubMed ID: 11380471
[TBL] [Abstract][Full Text] [Related]
54. Translocations into human chromosome 14 JH region: factors influencing downstream abortive immunoglobulin class switching.
Hughes JA; Weckert HA; van Holst Pellekaan C; Benson EM; Dunn IS
Mol Immunol; 2003 Dec; 40(9):573-83. PubMed ID: 14597160
[TBL] [Abstract][Full Text] [Related]
55. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
56. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
[TBL] [Abstract][Full Text] [Related]
57. Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination.
Schwindt H; Akasaka T; Zühlke-Jenisch R; Hans V; Schaller C; Klapper W; Dyer MJ; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2006 Aug; 65(8):776-82. PubMed ID: 16896311
[TBL] [Abstract][Full Text] [Related]
58. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
[TBL] [Abstract][Full Text] [Related]
59. IgH class switching and translocations use a robust non-classical end-joining pathway.
Yan CT; Boboila C; Souza EK; Franco S; Hickernell TR; Murphy M; Gumaste S; Geyer M; Zarrin AA; Manis JP; Rajewsky K; Alt FW
Nature; 2007 Sep; 449(7161):478-82. PubMed ID: 17713479
[TBL] [Abstract][Full Text] [Related]
60. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
Haluska FG; Tsujimoto Y; Croce CM
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
